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Abstract
Interferon regulatory factors (IRF)-3 and IRF-7 are master transcriptional factors that regulate type I IFN gene (IFN-a/b)
induction and innate immune defenses after virus infection. Prior studies in mice with single deletions of the IRF-3 or IRF-7
genes showed increased vulnerability to West Nile virus (WNV) infection. Whereas mice and cells lacking IRF-7 showed
reduced IFN-a levels after WNV infection, those lacking IRF-3 or IRF-7 had relatively normal IFN-b production. Here, we
generated IRF-3
2/26IRF-7
2/2 double knockout (DKO) mice, analyzed WNV pathogenesis, IFN responses, and signaling of
innate defenses. Compared to wild type mice, the DKO mice exhibited a blunted but not abrogated systemic IFN response
and sustained uncontrolled WNV replication leading to rapid mortality. Ex vivo analysis showed complete ablation of the
IFN-a response in DKO fibroblasts, macrophages, dendritic cells, and cortical neurons and a substantial decrease of the IFN-b
response in DKO fibroblasts and cortical neurons. In contrast, the IFN-b response was minimally diminished in DKO
macrophages and dendritic cells. However, pharmacological inhibition of NF-kB and ATF-2/c-Jun, the two other known
components of the IFN-b enhanceosome, strongly reduced IFN-b gene transcription in the DKO dendritic cells. Finally, a
genetic deficiency of IPS-1, an adaptor involved in RIG-I- and MDA5-mediated antiviral signaling, completely abolished the
IFN-b response after WNV infection. Overall, our experiments suggest that, unlike fibroblasts and cortical neurons, IFN-b
gene regulation after WNV infection in myeloid cells is IPS-1-dependent but does not require full occupancy of the IFN-b
enhanceosome by canonical constituent transcriptional factors.
Citation: Daffis S, Suthar MS, Szretter KJ, Gale M, Jr., Diamond MS (2009) Induction of IFN-b and the Innate Antiviral Response in Myeloid Cells Occurs through an
IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7. PLoS Pathog 5(10): e1000607. doi:10.1371/journal.ppat.1000607
Editor: Ganes Sen, Cleveland Clinic, United States of America
Received March 11, 2009; Accepted September 8, 2009; Published October 2, 2009
Copyright:  2009 Daffis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by NIH grants AI057568, U54 AI081680, U19 AI083019, and AI074973. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: diamond@borcim.wustl.edu
Introduction
The rapid production of type I interferon (IFN-a/b) and the
IFN-induced antiviral response serve as primary host defense
mechanisms against infection by many viruses (reviewed in [1–3]).
IFN-a/b gene transcription is induced after host pattern
recognition receptors (PRR) bind pathogen-associated molecular
patterns (PAMP), such as viral nucleic acids (reviewed in [4–6]). A
current paradigm for type I IFN production after RNA virus
infection describes a two-step or positive feedback model that is
modulated by the master transcription factors interferon regula-
tory factors (IRF)-3 and -7 [7–9]. In the initial phase, viral sensing
by PRR induces nuclear localization of IRF-3, which stimulates
gene transcription and production of IFN-b and IFN-a4b y
infected cells. In the second phase, these IFNs bind to a common
IFN-a/b receptor in a paracrine and autocrine manner and signal
through the JAK-STAT pathway resulting in the induced
expression of hundreds of interferon stimulated genes (ISG) (e.g.,
PKR, RNAse L, viperin, ISG15, and ISG20), which limit viral
replication through multiple mechanisms [10–13]. Whereas IRF-3
is constitutively expressed throughout many tissues and functions
downstream of specific PRR (e.g., TLR3, MDA5, and RIG-I) to
inhibit RNA viruses, IRF-7 is both an ISG and a transcriptional
activator downstream of distinct PRR (e.g., TLR7 and TLR8);
IRF-7 participates in an IFN amplification loop by inducing IFN-b
and many subtypes of IFN-a [14].
Recognition of West Nile virus (WNV), a neurotropic virus of
the Flaviviridae family of RNA viruses, by the intrinsic cellular
immune response is believed to occur through concerted signals by
several PRR (TLR3, TLR7, TLR8, RIG-I, and MDA5) that
recognize single or double-stranded RNA and signal through their
constituent adaptor molecules (TRIF, MyD88, and IPS-1). Tissue
culture experiments with murine embryonic fibroblasts (MEF)
suggested that RIG-I is an initial and primary PRR for WNV as
genetically deficient cells had an abrogated ISG response at early
time points after infection [15]. The late ISG response appears
more dependent on MDA5, suggesting a dual requirement of both
RIG-I and MDA5 for activation of an effective cellular antiviral
response against WNV, at least in MEF [16]. In contrast, a
deficiency of TLR3 in MEF, macrophages, and dendritic cells did
not alter IFN-a/b production or viral burden, indicating a more
limited role of this sensor in recognizing WNV in these cell types
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role of TLR7 and TLR8 in the priming of IFN responses after
WNV infection in cells. A recent study demonstrated no decrease
in systemic production of type I IFN in TLR7
2/2 mice infected
with WNV [18]. However, investigations with other RNA viruses
suggest that the TLR7/MyD88/IRF-7 axis regulates type I IFN
responses in specific subsets of dendritic cells [19,20].
Studies with genetically deficient mice have established an
important role of IRF-3 in protection against lethal WNV infection
by controlling viral burden in peripheraland centralnervous system
(CNS) tissues without affecting the systemic type I IFN response
[21]. Experiments performed with primary cells established that
IRF-3 restricts WNV replication in cortical neurons and MEF
throughtype I IFN-dependent mechanismswhereasinmyeloidcells
IRF-3 limits WNV infection independently of IFN by regulating
basal or WNV-induced expression of host defense molecules [21].
More recent studies demonstrated a pivotal role of IRF-7 in vivo in
controlling WNV infection [22]. IRF-7
2/2 mice developed
markedly elevated WNV burdens in multiple tissues and had a
blunted systemic type I IFN response. Studies with primary cells
showed that IRF-7 controls WNV infection largely through an IFN-
a-dependent mechanism. Surprisingly, the IFN-b response re-
mained intact suggesting possible redundant effects of IRF-3 and
IRF-7 in regulating IFN-b gene expression. These results agree with
an independent studyinwhichIRF-7
2/2 MEFinfected withherpes
simplex (HSV), vesicular stomatitis (VSV), or encephalomyocarditis
(EMCV) virus showed residual IFN-b responses that were abolished
in IRF-3
2/26IRF-7
2/2 MEF [14].
To understand the combined roles of IRF-3 and IRF-7 in innate
immune programs following WNV infection in vivo, we generated
IRF-3
2/26IRF-7
2/2 double knockout (DKO) mice. An absence
of both IRF-3 and IRF-7 led to uncontrolled WNV replication in
tissues and more rapid death than either of the single gene
deletions. Although severe, the DKO phenotype did not
recapitulate that observed in congenic IFN-abR
2/2 mice. Despite
a complete absence of both IRF-3 and IRF-7, IFN-b induction
remained largely intact in some cell types. Remarkably, in
experiments with myeloid dendritic cells (mDC) ex vivo, the
IFN-b response after WNV infection was abolished by the absence
of IPS-1 but was largely unaffected by a combined deficiency or
the transcription factors IRF-3 and IRF-7 or individual deficien-
cies of IRF-1, IRF-5, or IRF-8. However, pharmacological
inhibition of signaling by both NF-kB and ATF-2/c-Jun, the
two other factors, beside IRF-3 and IRF-7, that form the IFN-b
gene transcriptional complex enhanceosome [23–25], strongly
reduced the IFN-b response in DKO but not wild type mDC after
WNV infection. These studies define cell type-specific molecular
mechanisms and roles for IRFs in antiviral defense, and reveal a
differential requirement for components of the enhanceosome in
inducing the IFN-b gene in response to RNA viruses.
Results
Increased lethality of DKO mice after infection with WNV
Because of the possible functional redundancy of IRF-3 and
IRF-7, and to fully evaluate their net contribution to the regulation
of the IFN-b transcriptional response after WNV infection, we
generated IRF-3
2/26 IRF-7
2/2 (DKO) mice. These animals
were infected subcutaneously with 10
2 PFU of a highly pathogenic
New York strain of WNV. Whereas wild type C57BL/6 mice
exhibited a ,60% survival rate, congenic DKO mice displayed a
severe phenotype with 100% mortality and a mean time to death
of 6.0 days (Fig 1A). In comparison, IRF-3
2/2 or IRF-7
2/2 single
knockout mice infected with the same dose of WNV also had a
100% mortality rate but with mean time to deaths of 9.3 and 7.4
days, respectively [21,22].
As IRF-3 and IRF-7 are key regulators of the type I IFN
response to viral infection, we also compared the DKO phenotype
with congenic IFN-abR
2/2 mice. Similar to what we previously
observed [13,26], IFN-abR
2/2 mice were vulnerable to WNV
infection with 100% mortality by 4 days and a mean time to death
of 3.5 days (Fig 1A,P ,0.001 of average survival time compared
to DKO mice). Thus, although a combined deficiency of IRF-3
and IRF-7 has a more severe phenotype after WNV infection than
their respective single deficiencies, the survival pattern did not fully
recapitulate that observed in IFN-abR
2/2 mice, suggesting type I
IFN induction and/or regulation after WNV infection may
require additional transcriptional regulators.
DKO mice show uncontrolled WNV replication in tissues
To more completely evaluate the impact of the IRF-3 and IRF-
7 deficiency on WNV pathogenesis in vivo, wild type and DKO
mice were infected subcutaneously with 10
2 PFU of WNV and
viral burden was measured by fluorogenic quantitative RT-PCR
or viral plaque assay at days 1, 2, 3, 4, 5, 6 and 8 in blood,
peripheral organs (draining lymph nodes, spleen and kidney) and
the CNS tissues (brain and spinal cord) (Fig 1B–G).
Elevated viremia was observed in DKO mice when compared
to wild type mice (Fig 1B). By one day after infection, ,10
1.5-fold
higher levels of viral RNA (P,0.0001) were detected in the DKO
mice. Markedly enhanced (10
4.6 to 10
6.2-fold increase, P,0.0001)
WNV RNA levels were observed in serum of DKO mice on days 2
through 5, after which most animals succumbed to infection.
In the draining lymph nodes, similarly high levels (10
2.8 to 10
5.0-
fold increase, P,0.0001) of WNV RNA were observed in the
DKO mice throughout infection (Fig 1C). In the spleen, infectious
WNV was not detected in wild type mice until day 3. In contrast,
all DKO mice (10 of 10) had markedly elevated viral titers by day
2 (mean titer of 10
7.7 PFU/g) (Fig 1D). Although WNV infection
gradually increased in the spleens of wild type mice at days 3
through 5, significantly higher (10
4.5 to 10
4.9-fold) viral burdens
Author Summary
West Nile virus (WNV) is a mosquito-transmitted virus that
infects birds, horses, and humans and has become an
emerging infectious disease threat in the Western
Hemisphere. In humans, WNV can invade into the brain
and spinal cord and destroy neurons, causing severe
neurological disease, particularly in the immunocompro-
mised and elderly. A better understanding of how the
immune system controls WNV infection is critical for
developing new treatments and vaccines. In this study,
using a mouse model of WNV infection, we evaluate the
combined role of two key transcription factors, interferon-
regulatory factor-3 (IRF-3) and IRF-7, that orchestrate
antiviral and interferon (IFN) responses after infection.
Mice that lack both IRF-3 and IRF-7 were highly vulnerable
to lethal infection and cells lacking IRF-3 and IRF-7 had a
markedly attenuated IFN-a response. Surprisingly, macro-
phages and dendritic cells lacking IRF-3 and IRF-7 showed
a relatively normal IFN-b response. Furthermore, a genetic
deficiency of IPS-1, a protein that signals downstream of
the RIG-I- and MDA5 cytoplasmic viral RNA sensors,
completely abolished IFN-b production. Our experiments
suggest that in specific cell types infected with WNV, IFN-b
can be induced through an IPS-1-dependent transcrip-
tional signal that does not require the master transcrip-
tional regulators IRF-3 and IRF-7.
IFN Induction in IRF3/7 DKO Mice and Cells
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observed in DKO mice with significant infection of the kidneys
(e.g. 10
5 PFU/g, by day 2 and 10
7.5 PFU/g, by day 5, Fig 1E),
whereas wild type mice showed no productive infection of the
kidneys. Thus, a combined deficiency of IRF-3 and IRF-7 results
in sustained and elevated WNV infection in peripheral compart-
ments including spread to and propagation within normally non-
permissive organs.
Analysis of viral burden in the brain and spinal cord showed a
rapid entry of WNV into the CNS of DKO mice. WNV was
detected in all brains from DKO mice at day 2 compared to wild
type mice, where WNV was not observed until day 5 (Fig 1F).
Figure 1. Survival and viral burden analysis in mice. A. Eight to 12 week-old C57BL/6 mice were inoculated with 10
2 PFU of WNV by footpad
injection and followed for mortality for 21 days. Survival differences were statistically significant between immunodeficient and wild type mice
(n=11, IFN-abR
2/2; n=20, DKO; and n=20, wild type mice, P,0.0001). Average survival time between IFN-abR
2/2 (3.5 days) and DKO (6 days) mice
was also statistically different (P,0.001). B–G. Viral burden in peripheral and CNS tissues after WNV infection. WNV RNA in (B) serum and (C) draining
lymph node, and infectious virus in (D) spleen, (E) kidney, (F) brain and (G) spinal cord were determined from samples harvested on the indicated
days using qRT-PCR (B and C) or viral plaque assay (D–G). Data is shown as viral RNA equivalents or PFU per gram of tissue for 10 to 12 mice per time
point. For all viral load data, the solid line represents the median PFU per gram at the indicated time point, and the dotted line represents the limit of
sensitivity of the assay.
doi:10.1371/journal.ppat.1000607.g001
IFN Induction in IRF3/7 DKO Mice and Cells
PLoS Pathogens | www.plospathogens.org 3 October 2009 | Volume 5 | Issue 10 | e1000607Notably, at day 5, DKO mice had ,10
5.2 -fold higher viral titers
in the brain compared to wild type mice. A similar pattern was
observed in the spinal cord of DKO mice with all animals showing
markedly elevated viral loads after day 2 (Fig 1G). In contrast, in
wild type mice, infectious WNV was not detected in the majority
of animals until day 8 after infection. Thus, a combined absence of
IRF-3 and IRF-7 results in early neuroinvasion and uncontrolled
WNV replication.
The systemic type I IFN response in DKO mice is blunted
but not abolished
Previous studies have reported that an absence of IRF-3 in vivo
does not profoundly reduce the levels of type I IFN in serum after
WNV [21,27] or other viral infections [14]. In contrast, IRF-7
2/2
mice infected with WNV had a reduced but not abrogated
systemic IFN response [22]. We therefore used the DKO mice to
define whether signaling through IRF-3 could explain the residual
systemic type I IFN response after WNV infection in IRF-7
2/2
mice. Using a highly sensitive L929 cell bioassay, we compared the
serum IFN levels in DKO and wild type mice after WNV
infection. As observed previously [21,22], in wild type mice type I
IFN was detected in serum by day 1 with peak levels measured at
days 3 and 4 after infection (Fig 2). In contrast, in the DKO mice,
serum IFN levels at day 1 were below the detection level (0.01 IU/
ml) of the assay. Despite the higher viremia, serum IFN levels in
the DKO mice were reduced at days 2, 3 and 4 when compared to
wild type animals (,5 to 14-fold lower, P,0.005), but were not
abolished. This antiviral activity in the serum of infected DKO
mice was confirmed as type I IFN-dependent by depletion
experiments with a neutralizing mAb against the IFN-a/bR (data
not shown). Thus, a combined deficiency of IRF-3 and IRF-7 in
vivo delays and diminishes the accumulation of type I IFN in
serum. However, over time, type I IFN accumulates in the serum
of DKO mice after WNV infection. Thus, additional regulatory
factors must contribute to the systemic IFN response. Notably,
these results agree with a recent study in which independently-
generated DKO mice infected with mouse cytomegalovirus
(MCMV) showed a residual systemic IFN response that was
entirely specific for IFN-b [28].
IRF-3 and IRF-7 are required for the type I IFN and ISG
response in MEF after WNV infection
To better understand the net effect of IRF-3 and IRF-7 on
WNV infection and induction of a protective IFN response, we
infected primary cells from DKO and wild type mice. Because
MEF have been studied extensively in virus infection-host immune
response assays [16,29,30], we initially evaluated the effect of an
IRF-36IRF-7 deficiency in these cells. Previous experiments had
shown a blunted IFN-a response and a normal IFN-b response in
IRF-7
2/2 MEF infected with WNV [22]. In contrast, IRF-3
2/2
MEF had a diminished IFN-a and -b response early after infection
but developed normal levels at later time points (S. Daffis and M.
Diamond, unpublished data). In DKO MEF, IFN-a mRNA and
protein secretion were completely abolished after WNV infection
(Fig 3A and 3B). Similarly, levels of IFN-b mRNA were strongly
reduced at 24 h (,70-fold decrease, P,0.0001) and 48 h after
infection (,130-fold decrease, P,0.0001) but not entirely
abolished (Fig 3C). Measurement of secreted IFN-b in the cell
supernatants corroborated these findings as a ,4 and 20-fold
reduction (P,0.0001) was observed in DKO MEF at 24 and
48 hours, respectively (Fig 3D). Thus, normal induction of IFN-a
and IFN-b in MEF after WNV infection primarily requires
transcriptional activation by IRF-3 and IRF-7.
We next assessed the expression pattern of selected ISG
including ISG49, ISG54 and RIG-I by Western blot analysis. In
wild type MEF, these proteins become rapidly induced at 24 h
after infection and were sustained at 48 h. In contrast, induction
was absent in DKO MEF at 24 h after infection and levels were
comparably reduced at 48 h (Fig 3E). To assess how this
phenotype affected WNV replication, multi-step viral growth
analysis was performed (Fig 3F). Although no difference in viral
titers was observed at 24 hours, enhanced WNV replication was
seen at 48 h (13-fold, P=0.004) and 72 h (58-fold, P,0.0001) in
DKO MEF. Moreover, the levels of WNV at 48 and 72 h in the
DKO MEF were greater than those previously observed with the
single IRF-3
2/2 or IRF-7
2/2 MEF (S. Daffis and M. Diamond,
unpublished results and [22]). As IRF-3 and IRF-7 appear to
primarily regulate the IFN and ISG responses in MEF, we
predicted that the WNV replication phenotype in the DKO MEF
should not differ substantially from congenic IFN-abR
2/2 MEF.
Indeed, when directly compared, only small differences in viral
growth were observed between DKO and IFN-abR
2/2 MEF (2.7
fold, P,0.03 at 48 h and 2.3 fold, P,0.002 at 72 h) (Fig 3F).
IRF-3 and IRF-7 regulate the type I IFN and ISG response
in cortical neurons after WNV infection
To evaluate the combined roles of IRF-3 and IRF-7 in control
of viral replication and the IFN response in neuronal cells, we
assessed WNV infection of primary cortical neurons isolated from
DKO mice. Analysis of viral growth kinetics confirmed that IRF-3
and IRF-7 restrict WNV replication as a ,5 to 6-fold increase
(P,0.0001) in viral titer was observed at 24 h and 48 h compared
to wild type cells (Fig 4A). Somewhat surprisingly, the DKO
neurons did not show increased replication relative to cells lacking
either IRF-3 or IRF-7 (data not shown and [21,22]). The relatively
modest replication phenotype in the absence of IRF-3 and IRF-7
is consistent with only a small IFN-dependent antiviral effect in
these cells: IFN-a or -b pre-treatment inhibits WNV infection in
cortical neurons a maximum of 5 to 8-fold [13]. Analysis of the
IFN response of WNV-infected DKO neurons showed a complete
ablation of the IFN-a gene induction confirming results with the
IRF-7
2/2 cortical neurons [22] (Fig 4B). In contrast, and unlike
that observed with MEF or other primary myeloid cells (see
Figure 2. Levels of type I IFN levels in serum of wild type and
DKO mice infected with WNV. Mice were inoculated with 10
2 PFU of
WNV by footpad injection and sacrificed at the indicated times. Type I
IFN levels were determined from serum collected on days 1 to 4 after
WNV infection by an EMCV bioassay in L929 cells. Data reflect averages
of serum samples from 5 to 10 mice per time point and the data are
expressed as international units (IU) of IFN-a per ml. The specificity of
the assay was confirmed with an anti-IFN-abR neutralizing antibody
(data not shown). Asterisks indicate values that are statistically
significant (**, P,0.005, *, P,0.05).
doi:10.1371/journal.ppat.1000607.g002
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also entirely abolished (Fig 4C). Consistent with this, analysis of
ISG in DKO neurons showed a complete loss of induction of
ISG54, RIG-I and MDA5 following WNV infection (Fig 4D).
Thus, in cortical neurons coordinate signals through the
transcriptional regulators IRF-3 and IRF-7 are required for
IFN-a and IFN-b gene induction after WNV infection.
IFN-b response in Mw after WNV infection is partially IRF-
3 and IRF-7-dependent
As previous studies suggested cell type-specific differences in
type I IFN induction [21], we evaluated the effect of the combined
IRF-3 and IRF-7 deficiency in macrophages (Mw), a cell type that
is permissive to WNV in vivo [26]. Prior experiments established
that Mw lacking either IRF-3 or IRF-7 were more susceptible to
WNV infection [21,22]. Analogously, DKO Mw supported
increased WNV replication (,35, 250 and 310-fold, P,0.0001
at 24, 48 and 72 h after infection, respectively) compared to wild
type or even IRF-3
2/2 or IRF-7
2/2 singly deficient cells (Fig 5A
and [21,22]). In contrast to that observed with MEF (see Fig 3),
the DKO Mw produced ,14-fold less (P,0.05) WNV at 72 h
compared to IFN-abR
2/2 Mw infected in parallel. Thus, an
absence of both IRF-3 and IRF-7 in Mw did not recapitulate the
replication phenotype of IFN-abR
2/2 cells. As such a discrepancy
could be related to differences in the type I IFN and/or ISG
response, we analyzed these in DKO Mw after WNV infection. As
expected, levels of IFN-a mRNA were completely abolished
(Fig 5B), consistent with results from IRF-7
2/2 Mw [22].
Whereas IFN-b mRNA levels were reduced at 24 h after infection
in DKO Mw, they accumulated to normal levels by 48 h (Fig 5C).
Western blot analysis of ISG expression confirmed this pattern, as
the early induction of several ISG was altered at 24 h but not 48 h
Figure 3. IRF-3 and IRF-7 control the IFN-a/b gene induction and ISG expression in MEF. A–D. MEF generated from wild type or DKO mice
were infected at an MOI of 0.1 and analyzed for IFN-a/b gene induction. Total RNA from uninfected and WNV-infected MEF was harvested at the
indicated times after infection and levels of (A) IFN-a and (C) IFN-b mRNA were measured by qRT-PCR. Data are normalized to 18S rRNA and are
expressed as the relative fold increase over normalized RNA from uninfected controls. Accumulation of (B) IFN-a and (D) IFN-b protein in
supernatants was evaluated by ELISA. E. Whole cell lysates were generated at the indicated times from wild type or DKO MEF that were uninfected
(Un) or infected with WNV (W). Protein levels of ISG49, ISG54, RIG-I, WNV and tubulin were examined by immunoblot analysis. F. MEF generated from
wild type, IFN-abR
2/2 and DKO mice were infected at an MOI of 0.001 and virus production was evaluated by plaque assay. The data is the average of
at least three independent experiments performed in quadruplicate, (***, P,0.0001).
doi:10.1371/journal.ppat.1000607.g003
IFN Induction in IRF3/7 DKO Mice and Cells
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Mw, IRF-3 and IRF-7 coordinately regulate the early but are
dispensable for the later IFN-b and ISG responses.
IRF-3 and IRF-7 are also dispensable for the IFN-b
response in mDC after WNV infection
Because mDC are likely early targets for WNV infection in
animals [31–33] and help orchestrate innate and adaptive antiviral
immune responses [34], we evaluated IFN and ISG responses in
bone marrow-derived mDC. Prior studies showed that mDC
lacking either IRF-3 or IRF-7 support enhanced WNV replica-
tion, IRF-3
2/2 mDC developed normal IFN-a/b responses after
WNV infection, and IRF-7
2/2 mDC had reduced IFN-a but
relatively intact IFN-b responses after WNV infection (S. Daffis
and M. Diamond, unpublished results and [22]). Multi-step
growth curve analysis of DKO mDC infected with WNV showed
a higher viral burden compared to wild type cells (16 to 95-fold,
P,0.0001) and IRF-3
2/2 or IRF-7
2/2 mDC (Fig 6A, S. Daffis
and M. Diamond, unpublished results, and [22]). The viral titers
in DKO mDC were similar to those obtained in IFN-abR
2/2
mDC, suggesting a defect in type I IFN signaling in the DKO cells.
Surprisingly, whereas levels of IFN-a mRNA and protein were
abolished (Fig 6B and 6C), induction of IFN-b gene and protein
production was not significantly affected (P.0.2) after WNV
infection of DKO mDC (Fig 6D and 6E). Thus, in mDC, IRF-3
and IRF-7 regulate the IFN-a response but are largely dispensable
for inducing IFN-b after WNV infection. Western blot analysis of
ISG corroborated these findings as similar levels of ISG were
observed in wild type and DKO mDC at 24 and 48 h after WNV
infection (Fig 6F). These data suggest that the expression of ISG is
primarily IFN-b-dependent or that the IFN-a and -b have
redundant effects in these cells. Nonetheless, as higher viral
replication was sustained in DKO mDC despite a relatively
normal IFN-b response and ISG expression profile, it remains
possible that IRF-3 directly regulates expression of a key subset of
ISG that accounts for anti-WNV activity in this cell type.
To determine whether the IFN-b induction response in DKO
mDC was specific for WNV, we performed experiments with
agonists for the TLR3 and TLR4 pathways and with unrelated
viruses (Chikungunya virus (CHIK), an emerging human alpha-
virus, and EMCV, a model rodent picornavirus). As expected, wild
type mDC that were treated extracellularly with TLR3 (poly I:C)
or TLR4 (LPS) agonists rapidly induced IFN-b mRNA (Fig 7A).
In DKO cells, and in contrast to that observed with WNV, the
IFN-b response downstream of TLR treatment was effectively
abolished. Thus, activation of the IFN-b response in mDC after
TLR3 and TLR4 stimulation requires both IRF-3 and IRF-7. To
define whether the IRF-3/IRF-7-independent IFN-b response was
specific to WNV, we infected mDC with additional RNA viruses
(Fig 7B). In wild type mDC, EMCV infection induced a robust
IFN-b response similar to WNV, and high levels of IFN-b mRNA
were detected by 24 hours post infection (,100-fold increase).
Infection with CHIK at a higher MOI also resulted in a similar
IFN-b gene induction at 24 hours post infection. In DKO cells,
the IFN-b response after infection with WNV, EMCV, and CHIK
was equivalent to that observed in wild type cells. Thus, in mDC,
IRF-3 and IRF-7 are dispensable for activation of IFN-b gene
transcription, not only in response to WNV but also to other
positive strand RNA viruses that are genetically unrelated.
Figure 4. IRF-3 and IRF-7 restrict WNV infection by regulating the IFN-a/b response and ISG expression in primary cortical neurons.
A. Primary cortical neurons generated from wild type or DKO mice were infected at an MOI of 0.001 and virus production was evaluated at the
indicated times by plaque assay. Values are an average of triplicate samples generated from three independent experiments. Asterisks indicate values
that are statistically significant (***, P,0.0001). B and C. Levels of (B) IFN-a and (C) IFN-b mRNA in WNV-infected cortical neurons were measured by
qRT-PCR as described in the legend of Figure 3. D. Whole cell lysates were generated at the indicated times from wild type or DKO MEF that were
uninfected (Un) or infected with WNV (W). Protein levels of ISG54, RIG-I, and MDA5 were examined by immunoblot analysis. The data is the average of
at least three independent experiments performed in quadruplicate (***, P,0.0001).
doi:10.1371/journal.ppat.1000607.g004
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rely on type I IFN signaling and IRF-1 or IRF-8
To begin to investigate the mechanism(s) that regulate IFN-b
gene induction in mDC, we infected IRF-1
2/2 and IRF-8
2/2
mDC with WNV. These transcription factors have been
implicated in type I IFN gene transcription in DC after TLR
stimulation or viral infection [35,36]. Notably, no difference in
IFN-a and IFN-b mRNA levels was observed in IRF-1
2/2 mDC
(Fig 8A and 8B). Subsequently, we assessed whether the regulator
of IFN-b transcription was IFN-inducible, as has been suggested
for IRF-8 in the context of infection by MCMV [36] or
paramyxovirus [37]. IFN-abR
2/2 mDC were infected with
WNV and the levels of IFN-a and IFN-b mRNA were measured.
Whereas the IFN-a response was diminished in these cells, likely
because of the abolition of the type I IFN positive feedback loop
(Fig 8C), the IFN-b gene response in IFN-abR
2/2 mDC was
greater (5 to 10-fold, P,0.05) compared to wild type cells (Fig 8D).
These results suggest that, unlike the regulation of the IFN-a
response, activation of the IFN-b gene after WNV infection in
mDC is independent of the type I IFN positive feedback loop.
Consistent with this, no difference in IFN-a and IFN-b induction
was observed after WNV infection of IRF-8
2/2 mDC (Fig 8A
and 8B).
Recent studies have suggested that IRF-5 can activate
transcription of IFN and other inflammatory cytokine genes after
viral infection or TLR stimulation [38–41]. As IRF-5 also has
been implicated in IFN production and protection in vivo after
infection by negative strand RNA viruses (Newcastle Disease virus
(NDV) and VSV) and DNA viruses (HSV) [38,42], we evaluated
whether the transcriptional signal after WNV infection of mDC
cells was dependent on IRF-5. IRF-5
2/2 mDC showed only a
modest yet reproducible reduction (2.5-fold, P,0.05) in IFN-b
gene transcription within 24 hours of WNV infection (Fig 8D). By
48 hours, however, these deficits were no longer apparent as
equivalent or even greater levels of IFN-b mRNA were detected in
IRF-5
2/2 cells. Taken together, our experiments suggest that
IRF-1 and IRF-8 are dispensable for induction of IFN-b gene
transcription in mDC, whereas an IRF-5 has a small and transient
regulatory effect in these cells after WNV infection.
A combined inhibition of NF-kB and ATF-2/c-Jun in DKO
mDC reduces the IFN-b response after WNV infection
The transcriptional activation of the IFN-b gene requires full
occupancy of an enhancer complex known as the ‘‘enhanceo-
some’’ [23–25]. In vitro, the active IFN-b enhanceosome is formed
after association of the transcription factors IRF-3, IRF-7, ATF-2/
c-Jun, and NF-kB. Although synergy in transcription of the IFN-b
gene occurs after coordinate binding of these regulatory factors in
several cell types [25], the mechanistic basis for full occupancy of
the enhanceosome remains incompletely understood. Since a
combined deficiency of IRF-3 and IRF-7 only modestly reduced
the IFN-b gene induction in mDC after WNV infection, we
hypothesized that the residual IFN-b activity could occur through
a NF-kB-dependent and/or ATF-2/c-Jun-dependent signal that is
mediated directly through PRR signaling. To test this possibility,
we used the highly specific and validated pharmacological
inhibitors of NF-kB (BAY 11-7082) [43,44] and p38 MAP kinase
(SB 202190), which is essential for phosphorylating and activating
Figure 5. IRF-3 and IRF-7 partially modulate the IFN-b response and ISG expression in primary Mw.A .M w generated from wild type, IFN-
abR
2/2 and DKO mice were infected at an MOI of 0.01 and virus production was evaluated at the indicated times post infection by plaque assay.
Values are an average of quadruplicate samples generated from at least three independent experiments. B. Whole cell lysates were generated at the
indicated times from wild type and DKO Mw that were uninfected (Un) or infected with WNV (W). Protein levels of ISG49, ISG54, PKR, STAT1, RIG-I,
MDA5 and tubulin were examined by immunoblot analysis. C and D. The induction of (C) IFN-a and (D) IFN-b mRNA in WNV-infected Mw was
analyzed by qRT-PCR as described in Figure 3. Asterisks indicate values that are statistically significant (***, P,0.0001, **, P,0.005, *, P,0.05).
doi:10.1371/journal.ppat.1000607.g005
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increasing concentrations of BAY 11-7082, the NF-kB inhibitor,
yielded only a small reduction of WNV-induced IFN-b response
(maximum of 3.9 fold decrease, P=0.006) (Fig 9A). In contrast,
the LPS-induced TNF-a response, which is dominantly regulated
by NF-kB [46,47], was dose-dependently inhibited in wild type
and DKO mDC treated with BAY 11-7082 (Fig 9C). Analo-
gously, treatment of DKO mDC with SB 202190 had a limited
effect on the WNV-induced IFN-b response (3.5 fold decrease,
P=0.02) (Fig 9A). Thus, in mDC lacking IRF-3 and IRF-7,
inhibition of NF-kB or ATF-2/c-Jun alone only modestly reduced
the IFN-b gene transcription after WNV infection. However, a
combined inhibition of both NF-kB and ATF-2/c-Jun in DKO
mDC strongly diminished the IFN-b response (29-fold decrease,
P,0.0001). In contrast, a more subtle decrease (2.5-fold decrease,
P=0.006) of IFN-b transcription after WNV infection was
observed in wild type mDC that retained expression of IRF-3
and IRF-7. Parallel experiments using an ATP metabolism assay
confirmed that the difference in effect by the inhibitors was not
due to differential cytotoxicity between wild type and DKO cells
(Fig 9A). These experiments suggest that, in mDC, efficient
activation of the IFN-b gene does not require the full enhanceo-
some occupancy, as a combined functional absence of IRF-3, IRF-
7, NF-kB and ATF-2/c-Jun is necessary to strongly inhibit the
IFN-b gene activation after WNV infection.
Since the activation of the IFN-b response in MEF was
markedly reduced in the absence of both IRF-3 and IRF-7, we
hypothesized that, in contrast to that observed in DC, the
regulation of the IFN-b gene in MEF would depend more strongly
on the full occupancy of the enhanceosome with canonical
constituents. To assess this, wild type MEF were treated with BAY
11-7082 and/or SB 202190, infected with WNV, and levels of
IFN-b mRNA were measured. In contrast to that observed with
wild type mDC, inhibition of NF-kB in wild type MEF slightly
decreased the IFN-b response (,2-fold decrease, P=0.01)
(Fig 9B). Similarly, inhibition of ATF-2/c-Jun in wild type MEF
Figure 6. The WNV-induced IFN-b response and ISG expression is primarily IRF-3 and IRF-7-independent in mDC. A. mDC generated
from wild type, IFN-abR
2/2 and DKO mice were infected at an MOI of 0.001 and virus production was evaluated at the indicated times post infection
by plaque assay. Values are an average of quadruplicate samples generated from at least three independent experiments (***, P,0.0001). B–E. Levels
of (B) IFN-a and (D) IFN-b mRNA as well as (C) IFN-a and (E) IFN-b protein in WNV-infected mDC were measured by qRT-PCR or ELISA as described in
the legend of Figure 3. F. Whole cell lysates were generated at the indicated times from wild type and DKO mDC that were uninfected (Un) or
infected with WNV (W). Protein levels of ISG49, ISG54, PKR, STAT1, RIG-I, MDA5 and tubulin were examined by immunoblot analysis.
doi:10.1371/journal.ppat.1000607.g006
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More strikingly, inhibition of both NF-kB and ATF-2/c-Jun in
wild type MEF strongly attenuated the IFN-b gene transcription
(,20-fold decrease, P,0.0001). Thus, disruption of function of
single components of the enhanceosome is sufficient to reduce the
IFN-b transcriptional response in MEF. Consistent with this,
inhibition of NF-kB and/or ATF-2/c-Jun in DKO MEF
essentially abolished the residual IFN-b response (Fig 9B). Taken
together, these data suggest that optimal regulation of the IFN-b
gene transcription in mDC, in contrast to MEF, does not require
complete occupancy four canonical components of the enhanceo-
some.
A deficiency of IPS-1 abolishes the IFN-b response in MEF
and mDC
Immune detection of WNV by mDC likely occurs through the
cytosolic PRR, RIG-I and MDA5 and requisite signaling through
the IPS-1 adaptor protein; this leads to activation of downstream
IRF family proteins and IFN gene transcription [16]. To better
understand the signaling pathway between PRR and IFN gene
induction after exposure to WNV, we infected IPS-1
2/2 MEF and
mDC. Whereas levels of IFN-a and -b mRNA increase over time in
wild type mDC and MEF, induction of both was virtually abolished
in IPS-1
2/2 cells (Fig 10A–D). Consistent with this, we did not
detect any secreted IFN-a and b from IPS-1
2/2 DC or MEF
supernatants (data not shown). Thus, the induction of type I IFN
genes in mDC or MEF after WNV infection is entirely dependent
on IPS-1 signaling. Since IRF-5 may play a partial role in IFN-b
gene regulation in mDC (Fig 8D) and since MyD88 has been
suggested to mediate the TLR- and IRF-5-dependent cell type-
specific induction of type I IFN after NDV infection [38], we also
assessed the role of MyD88 in triggering the IFN-b response in
mDC. As shown (Fig 10E and F), the IFN-a and b transcription
induced by WNV infection in mDC was essentially independent of
MyD88. Thus, an optimal IFN-b transcriptional signal in mDC
after WNV infection is generated through a pathway that requires
IPS-1, a subset of the four (IRF-3, IRF-7, NF-kB and ATF-2/c-Jun)
components of the canonical enhanceosome and possibly, IRF-5,
after a MyD88-independent activation signal.
TRAF3 and TBK1 regulate the early IPS-1-dependent type
I IFN response whereas TRAF6 modulates a later phase
Although our experiments suggested that IFN-b induction after
WNV infection required IPS-1 yet was mediated by a cell type-
specific complex of transcriptional regulators, the signaling
adaptors that connected these pathways remained uncertain. As
IPS-1-dependent regulation of the type I IFN genes in response to
VSV and Sendai virus requires activation of TRAF3 [48], we
infected TRAF3
2/2 MEF with WNV and measured the levels of
IFN-b mRNA and secreted cytokine. TRAF3
2/2 MEF showed a
significant reduction of IFN-b mRNA levels at 24 hours and
48 hours post infection (7.8-fold, P,0.0001 and 2.4-fold, P,0.05,
respectively), which was confirmed by measuring IFN-b in the cell
supernatant (3.7- and 1.4-fold decrease, respectively, P,0.0001)
(Fig 11B and 11D). These data suggest that initial IPS-1-
dependent trigger of the IFN-b response after WNV infection is
mediated at least partially by TRAF3. Consistent with this, the
levels of IFN-a mRNA and protein, which reflect the type I IFN
positive feedback, also were decreased in TRAF3
2/2 MEF
(mRNA: 32-fold and 36- fold decreases, P,0.0001; protein: 1.3-
fold, P,0.0001) (Fig 11A and 11C). As TBK1 is a kinase that
reportedly mediates the signal to induce IFN production
downstream of the IPS-1/TRAF3 axis [49], we assayed IFN-a/
b induction after WNV infection in TBK1
2/2 MEF. Similar to
that observed in TRAF3
2/2 MEF, the levels of mRNA and more
importantly, secreted IFN-b were decreased in TBK1
2/2 MEF
(3.7- and 1.5-fold decrease, respectively, P,0.0001) (Fig 11D).
However, levels of IFN-a mRNA and secreted cytokine in
TBK1
2/2 MEF were not different compared to wild type MEF
(P$0.2) (Fig 11A and 11C). Thus, TBK1 appears to mediate the
early IFN-b response downstream of TRAF3 after WNV infection
but appears dispensable for the later activation of IFN amplifica-
tion loop. Collectively, these data suggest that, in MEF, the early
IFN-b response depends on a signaling pathway involving IPS-1,
TRAF3, and TBK1 whereas the late IFN-b response may also
partially involve TRAF3. Unfortunately, because TRAF3
2/2 and
TBK1
2/2 mice are lethal shortly after birth [50,51], we could not
confirm this signaling pathway in mDC.
Recent studies with VSV-infected cells have suggested that
TRAF6 regulates the IPS-1-dependent signal to induce type I IFN
[52]. To evaluate the contribution of TRAF6 to induction of the
IFN response after WNV infection, levels of mRNA and IFN-b
secreted protein were assayed in TRAF6
2/2 MEF. In contrast to
Figure 7. The IFN-b response in mDC after TLR stimulation and
viral infection. mDC generated from wild type and DKO mice were
(A) stimulated with 50 mg/ml of poly(I:C) or 2 mg/ml LPS for 24 h or (B)
infected with EMCV (MOI 0.1), WNV (MOI 0.1) and CHIK (MOI 1) for 24 h.
Levels of IFN-b were measured either by ELISA or qRT-PCR. Values are
an average of triplicate samples generated from three independent
experiments. Asterisks indicate values that are statistically significant
(***, P,0.0001, ** P,0.0005) from wild type cells; n.s. indicates
differences that were not statistically significant.
doi:10.1371/journal.ppat.1000607.g007
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2/2 MEF, levels of mRNA and secreted
IFN-b in TRAF6
2/2 cells supernatants were equivalent to wild
type cells at 24 hours post infection (P.0.2) but slightly reduced at
48 hours (,2-fold decrease, P,0.0001) (Fig 11D). TRAF6
2/2
MEF, however, exhibited reduced IFN-a mRNA levels and
protein secretion (240-fold and 4-fold reduction, P,0.0001)
despite a relatively normal early IFN-b response (Fig 11A and
11C). Thus, TRAF6 appears dispensable for the early IFN-b gene
response but required for amplifying the late IFN-a and -b
responses in MEF. Our experiments suggest that TRAF3 and
TRAF6 have distinct and complementary functions in activating
the type I IFN response in MEF after WNV infection.
Discussion
Early protection of the host against viral infections relies on the
rapid detection of the pathogen and optimal activation of the type
I IFN response. Here, using mice and primary cells lacking
expression of both IRF-3 and IRF-7, we demonstrate that these
transcriptional activators have essential non-redundant functions:
DKO mice exhibited a more rapid lethality with enhanced tissue
viral burden compared to mice lacking either IRF-3 or IRF-7.
Associated with this profound virological phenotype, DKO mice
had attenuated levels of systemic type I IFN. A combined
deficiency of IRF-3 and IRF-7 however, showed heterogeneous
cellular IFN-b but not -a responses. Whereas IFN-a was virtually
abolished in all DKO cells tested, the IFN-b response was
sustained in DKO Mw and mDC. The uncoupling of virus
induction of IFN-b from IFN-a in DKO Mw and mDC establishes
a cell-type specificity and IRF-3/IRF-7-independence of this
pathway.
The combined absence of IRF-3 and IRF-7 largely abrogated
the IFN-a and b responses in primary fibroblasts and cortical
neurons. This data agrees with previous experiments showing loss
of IFN-a and -b gene induction in DKO MEF infected with HSV-
1, VSV, or EMCV [14]. In contrast, a deficiency of both IRF-3
Figure 8. The IFN-b response in mDC is IRF-1, IRF-8, IFN-a/b-independent but partially IRF-5-dependent. mDC generated from wild type,
(A and B) IRF-1
2/2, IRF-8
2/2,( C and D) IFN-a/bR
2/2,o r( E and F) IRF-5
2/2 mice were infected at an MOI of 0.1 and levels of IFN-a (A, C, and E) and
IFN-b (B, D, and F) mRNA were measured by qRT-PCR. Values are an average of triplicate samples generated from three independent experiments.
Asterisks indicate values that are statistically significant (***, P,0.0001, **, P,0.005, *, P,0.05) compared to wild type.
doi:10.1371/journal.ppat.1000607.g008
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Mw and mDC. Thus, IFN-b induction after WNV infection in
myeloid cells depends on IRF-3 and IRF-7-independent tran-
scriptional signals. This result is consistent with data showing
significantly reduced but not abrogated type I IFN levels in serum
of DKO mice after WNV infection. Analogously, a recent study
showed residual IFN-b activity in serum after MCMV infection in
independently generated DKO mice [28]. In blood, plasmacytoid
DC (pDC) are believed to be primary producers of type I IFN
during infection by RNA viruses [53,54]; in pDC, IFN is induced
after nucleic acid recognition by TLR7 and signaling through
MyD88 to IRF-7 [14,55]. As pDCs require IRF-7 for IFN
production, yet DKO mice still produce systemic levels of IFN
after WNV infection, non-pDC cell population(s) must contribute
to this response. This result agrees with recent data showing no
alteration of systemic type I IFN production in TLR7
2/2 mice
infected with WNV [18].
The current model for optimal IFN-b gene transcriptional
depends on complete occupancy of the enhanceosome of the IFN-
b gene promoter by the transcriptional factors IRF-3, IRF-7, NF-
kB and ATF-2/c-Jun. Coordinate transcription factor binding
enables recruitment of chromatin-remodeling proteins such as the
co-activators GCN5 and CBP/p300 [23,24]. Our data with MEF
lacking IRF-3 and IRF-7 show a requirement of all individual
enhanceosome constituents in efficiently regulating the IFN-b
response. Consistent with this, pharmacological inhibition of the
other enhanceosome constituents, NF-kB and ATF-2/c-Jun in
MEF expressing IRF-3 and IRF-7 also strongly reduced the
efficacy of IFN-b gene transcription. Surprisingly, this model did
not apply to mDC where only functional loss of all four
enhancesome components strongly diminished IFN-b gene
activation. Thus, in mDC, IFN-b expression after viral infection
can be induced robustly without full occupancy of the enhanceo-
some by the canonical transcriptional regulators. Although we do
not fully understand the molecular basis for the cell-type restriction
of enhanceosome occupancy and IFN-b gene induction, it is
possible that in myeloid cells other transcriptional regulators can
substitute for the canonical complex members to activate IFN-b
gene transcription. However, other individual IRF family
members (e.g., IRF-1 or IRF-8), which are known to induce the
IFN-b response after viral infection or engagement of PRR in
some systems [36,56–58], did not have a dominant regulatory
effect in the context of WNV infection. The role of IRF-2 and
IRF-4 was not specifically tested as these factors have been
reported as negative regulators of the type I IFN responses [59,60].
Nonetheless, we did observe a small yet transient reduction in the
IFN-b response after WNV infection in IRF-5
2/2 mDC and had
previously detected a similarly small (,2-fold) reduction in IFN-b
transcription in single-deficient IRF-7
2/2 mDC [22]. In contrast,
DKO mDC did not show altered IFN-b responses possibly
because of the higher level of WNV infection in these cells.
IRF-5 was initially characterized as a transcription factor
downstream of TLR-MyD88 signaling pathway that mediated
induction of pro-inflammatory cytokines (e.g., IL-6 and TNF-a)
excluding type I IFN [41]. More recent studies indicate that type I
IFN induction in mDC after treatment with TLR4, TLR7, or
TLR9 agonists is partially IRF-5-dependent [61,62]. IRF-5 is
critical for immunity against some viruses, as IRF-5
2/2 mice have
increased mortality and/or blunted systemic IFN production after
infection with VSV, HSV, and NDV [38,42]. One group recently
identified a new signaling pathway involving NOD2, RIP2 and
IRF-5 in modulating IFN-a/b gene induction in response to
Mycobacterium tuberculosis [63]. Although it remains unclear precisely
how IRF-5 regulates the IFN-b gene response or interacts with the
enhanceosome components, its expression could account for why
induction of the IFN-b response does not require complete
occupancy of canonical complex constituents in myeloid cells. The
Figure 9. Pharmacological inhibition of NF-kB and p38 in wild
type and DKO mDC and MEF. A–B. mDC (A) and MEF (B) generated
from wild type and DKO mice were infected at an MOI of 0.1 in the
presence of 1% DMSO or increasing concentrations of BAY 11-7082 (in
1% DMSO) and/or increasing concentrations of SB 202190 (in 1% DMSO).
Levels of IFN-b mRNA were evaluated at the indicated times post-
infection by qRT-PCR. Cell viability was analyzed using a cytotoxicity
assay as described in the Materials and Methods. C. Efficiency of BAY
11-7082 in inhibiting NF-kB transcriptional activity. Wild type and DKO
mDC were treated with 1% DMSO or 5 mM and 10 mM of BAY 11-7082
and stimulated with LPS (2 mg/ml) for 24 hours. Levels of secreted TNF-a
were measured by ELISA. Values are an average of duplicate samples
generatedfromthreeindependentexperiments. Asterisksindicatevalues
thatarestatistically significant(***,P,0.0001,**,P,0.005,*,P,0.05);n.s.
indicates differences that were not statistically significant.
doi:10.1371/journal.ppat.1000607.g009
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cells may help to address this question. Alternatively, a differential
level of histone acetylation of the IFN-b gene could exist in MEF
and mDC. A more ‘‘relaxed’’ chromatin structure of the IFN-b
gene in mDC might not require the coordinate recruitment of all
chromatin-remodeling proteins; thus, full occupancy of the
enhanceosome by transcription factors may not be a prerequisite
for optimal activation of IFN-b gene transcription in this cell type.
Our results also establish that IFN-b gene activation in several
cell types is largely IPS-1-dependent and likely occurs downstream
of RIG-I and MDA5 recognition of WNV RNA. This data is
consistent with studies in MEF, peritoneal exudates cells, and
mDC with NDV, VSV, EMCV, influenza and Sendai viruses
[1,16,64–66]. Similarly, a prior study with two related flaviviruses,
Japanese encephalitis and Dengue viruses suggested that IFN-b
gene induction in A549 lung carcinoma cells was through NF-kB
and RIG-I/IRF-3-dependent pathways [67]. Our data also agrees
with a previous study that observed no role for TLR3 in regulating
the IFN-a/b response in mDC after WNV infection [17]. The
IPS-1 dependence validates the primary role for RIG-I and/or
MDA5 in sensing WNV. Although both RIG-I and MDA5
coordinately contribute to IFN and ISG induction in MEF after
WNV infection [16], in mDC the RIG-I recognition pathway
appears dominant ([68] and M. Suthar, S. Daffis, M. Diamond,
and M. Gale, unpublished results).
Further dissection of the IPS-1-dependent signaling pathway in
MEFshoweda differentialroleofTRAF3 and TRAF6inregulating
IFN-b responses. Based on studies with deficient MEF, TRAF3
contributes dominantly to the early phase of IFN-b production,
likely by recruiting TBK1. Consistent with this, others have shown
Figure 10. The IFN-b response in mDC and MEF is IPS-1-dependent but MyD88-independent. mDC and MEF generated from wild type,
IPS-1
2/2 and MyD88
2/2, mice were infected at an MOI of 0.1 and levels of (A, C, and E) IFN-a and (B, D, and F) IFN-b mRNA were quantified by qRT-
PCR. Values are an average of duplicate samples generated from three independent experiments. Asterisks indicate values that are statistically
significant (***, P,0.0001).
doi:10.1371/journal.ppat.1000607.g010
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2/2 MEF infected with Sendai virus have a reduced
IFN-b response [69]. These results also agree with our unpublished
data in IRF-3
2/2 MEF; a deficiency of IRF-3, which is activated
primarily by TRAF3 [49], results in a blunted IFN-a/b response. In
contrast to TRAF3, TRAF6 had a more dominant function in
sustaining the type I IFN positive feedback. Thus, after WNV
infection, the type I IFN amplification loop appears mediated by
signals downstream of the IFN-abR receptor, which may include
induction and/or activation of IRF-7 and TRAF6. Since TRAF3
and TRAF6 activate IRF-3, NF-kB, and p38 in MEF [49,52],
induction of the late phase of type I IFN may require these signaling
adaptor molecules to activate the four components (IRF-3, IRF-7,
NF-kB and ATF-2/c-Jun) of the enhanceosome. Based on the data
presented here and elsewhere [16], we propose a model for host
detection of WNV, signaling through IPS-1 and key adaptor
molecules, and transcriptional activation of the IFN-a and b genes
at early and late times after infection of MEF (Fig 12).
In summary, our studies demonstrate that IRF-3 and IRF-7
coordinately play essential but differential roles in vivo in
protecting against WNV pathogenesis primarily by regulating
the IPS-1-dependent type I IFN responses through a cell type-
dependent mechanism. These studies illuminate the cell-specific
complexity of IFN induction and enhance our understanding of
how an effective innate response becomes activated soon after viral
infection. Greater insight into the molecular mechanisms of the
earliest protective antiviral immune response against WNV may
provide novel strategies for therapeutic intervention against many
related and unrelated viral pathogens.
Materials and Methods
Viruses
The WNV strain (3000.0259) was isolated in New York in 2000
[70] and passaged once in C6/36 Aedes albopictus cells to generate a
stock (5610
7 PFU/ml) that was used in all experiments. Chikungu-
n y av i r u s( s t r a i n1 4 2 ,g i f to fS .H i g g s ,U T M B )a n dE M C V( s t r a i nK )
were propagated in C6/36 and L929, respectively.
Mouse experiments and quantitation of viral burden
C57BL/6 wild-type mice were commercially obtained (Jackson
Laboratories, Bar Harbor, ME). IFN-ab receptor (IFN-abR)
2/2
congenic C57BL/6 mice were the kind gift of J. Sprent (La Jolla,
CA). The congenic backcrossed IRF-3
2/2 [37], IRF-5
2/2 [41],
and IRF-7
2/2 [14] mice were the kind gift of T. Taniguchi
(Tokyo, Japan) and provided generously by colleagues in the
United States (I. Rifkin, Boston, MA and K. Fitzgerald, Worcester,
MA). The IRF-1
2/2 mice were obtained commercially (Jackson
Laboratories). The IRF-8
2/2 mDC were obtained from bone
marrow of IRF-8
2/2 mice [36] and were a generous gift of P.
Tailor and K. Ozato (Bethesda, MD). The TRAF3
2/2 and
TRAF6
2/2 MEF were kindly provided by G. Cheng (UCLA, Los
Angeles, CA) and T. Mak (University of Toronto, Canada),
Figure 11. The early phase of the type I IFN regulation in MEF partially involves TRAF3 and TBK1 whereas the late phase requires
TRAF6. TRAF3
2/2, TBK1
2/2 and TRAF6
2/2 MEF were infected at an MOI of 0.1 and levels of (A and C) IFN-a and (B and D) IFN-b mRNA and secreted
protein were measured by qRT-PCR and ELISA. Since basal mRNA expression of the IFN-b gene in uninfected TBK1
2/2 and TRAF6
2/2 MEF was lower
than that observed in congenic wild type cells, for these cells only, we compared IFN-b mRNA levels to the wild type MEF. Values are an average of
duplicate samples generated from three independent experiments. Asterisks indicate values that are statistically significant (***, P,0.0001, **,
P,0.005, *, P,0.05); n.s. indicates differences that were not statistically significant.
doi:10.1371/journal.ppat.1000607.g011
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(Mount Sinai Hospital, NY). IRF-3
2/26 IRF-7
2/2 DKO mice
were generated after large-scale crossing and recombination in the
F1 generation because of the 1 cM linkage of the two loci. DKO
mice were genotyped and bred in the animal facilities of the
Washington University School of Medicine, and experiments were
performed with approval of the Washington University Animal
Studies Committee. Eight to twelve week-old age-matched mice
were used for all in vivo studies. 10
2 PFU of WNV was diluted in
Hanks balanced salt solution (HBSS) supplemented with 1% heat-
inactivated fetal bovine serum (FBS) and inoculated by footpad
injection in a volume of 50 ml.
Tissue viral burden and viremia
To monitor viral dissemination in vivo, mice were infected with
10
2 PFU of WNV by footpad inoculation and sacrificed at specific
time points after inoculation. After extensive cardiac perfusion
with PBS, organs were harvested, weighed, homogenized and
virus was titrated by standard plaque assay as described [71]. Viral
burden also was measured by analyzing WNV RNA levels using
fluorogenic quantitative RT-PCR (qRT-PCR) as described [13].
Measurement of IFN activity
(a) L929 bioassay. Levels of biologically active IFN in serum
were measured using an EMCV L929 cytopathic effect bioassay as
described [13]. Results were compared with a standard curve
using recombinant mouse IFN-a (PBL Laboratories) and
confirmed as IFN-specific using a neutralizing mAb (MAR-1)
against the IFN-abR [72].
(b) IFN-a and b mRNA by qRT-PCR. Total RNA was
isolated from uninfected or WNV-infected cells at specific time
points using the RNeasy kit (Qiagen). IFN-a and -b mRNA levels
were measured by qRT-PCR using previously established primer
sets [21]. To analyze the relative fold induction of IFN-a and b
Figure 12. A model for detection of WNV and IFN-a/b gene activation in MEF. (1). The host through recognition of an as yet undefined viral
RNA PAMP in the cytoplasm detects WNV. RIG-I acts as the primary PRR sensor for WNV during the early stages of infection. RIG-I activation promotes
association with IPS-1, which leads to recruitment of TRAF3 and TBK1, and phosphorylation of IRF-3. NF-kB and ATF-2/c-Jun and the small amounts of
constitutively expressed IRF-7 may also be activated via this IPS-1-dependent pathway. IRF-3, IRF-7 NF-kB, ATF-2/c-Jun translocate to the nucleus,
bind the IFN-b gene promoter and promote transcription. Secretion of IFN-b by infected cells during this early phase results in autocrine and
paracrine type I IFN signaling through binding of the IFN-abR. (2). Activation of IFN-abR results in phosphorylation of JAK1 and Tyk2, which activate
STAT1 and STAT2 leading to formation of the heterotrimer ISGF3 (STAT1, STAT2 and IRF-9). Nuclear translocation and promoter binding of ISGF3
upregulates hundreds of different ISG, including IRF-7. (3). During a later phase of infection, detection of WNV in MEF also relies on MDA5 and PKR.
Recruitment of TRAF3 and TRAF6 activates IRF-3 and IRF-7. NF-kB and ATF-2/c-Jun are also activated via an as yet undefined mechanism.
Subsequently, IRF-3, IRF-7, NF-kB, and ATF-2/c-Jun translocate to the nucleus, bind the IFN-b gene promoter and induce optimal transcription.
Induction of IFN-a genes occurs through TRAF6 and the transcriptional activation of IRF-7.
doi:10.1371/journal.ppat.1000607.g012
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for normalization using the Ct method [73].
(c) IFN-a and b ELISA. A commercial capture ELISA kit
(PBL Laboratories) was used to measure levels of secreted IFN-a
and b protein in supernatants or uninfected or WNV-infected cells.
Primary cell culture and viral infection
(a) Macrophages and dendritic cells. Bone marrow
derived Mw and conventional mDC were generated as described
previously [22]. Briefly, bone marrow cells were isolated from mice
and cultured for seven days in the presence of macrophage colony-
stimulating factor (M-CSF) (PeproTech, Inc.) to generate Mw,o r
interleukin-4 (IL-4) and granulocyte-macrophage colony-
stimulating factor (GM-CSF) (PeproTech, Inc.) to generate
mDC. Multi-step viral growth curves were performed after
infection at a multiplicity of infection (MOI) of 0.01 for Mw or
0.001 for mDC. Supernatants were titrated by plaque assay on
BHK21-15 cells. Quantitation of IFN-a and -b mRNA levels in
Mw and mDC was assessed after infection at a MOI of 0.1.
(b) Fibroblasts. MEF were generated from wild type and
deficient 14-day-old embryos and maintained in DMEM
supplemented with 10% FBS. Cells were used between passages
2 and 4 for all experiments. Multi-step virus growth curves and
IFN-a and b ELISA were performed after infection at an MOI of
0.001 and 0.1, respectively.
(c) Cortical neurons. Primary cortical neurons were
prepared from wild type and deficient 15-day-old mouse
embryos as described [13]. Cortical neurons were then cultured
for four days with Neurobasal medium containing B27 and L-
Glutamine (Invitrogen). Multi-step virus growth curves and IFN-a
and b protein quantitation were performed after infection at an
MOI of 0.001 and 0.1, respectively.
Toll-like receptor stimulation assays
mDC, generated as described above, were stimulated with
TLR3 ligand (50 mg/ml poly(I:C)) or TLR4 ligand (2 mg/ml LPS)
for 24 hours. Levels of IFN-a mRNA and IFN-b protein were
measured by qRT-PCR as described above.
Western blots
Primary cells (10
6) were lysed in RIPA buffer (10 mM Tris,
150 mM NaCl, 0.02% sodium azide, 1% sodium deoxycholate,
1% Triton X-100, 0.1% SDS, pH 7.4), with protease inhibitors
(Sigma) and 1 mM okadaic acid (Sigma). Samples (30 mg) were
resolved on 10% SDS-polyacrylamide gels. Following transfer,
membranes were blocked with 5% non-fat dried milk overnight at
4uC. Membranes were probed with the following panel of
monoclonal or polyclonal antibodies anti-WNV (Centers for
Disease Control), anti-tubulin, anti-STAT1, anti-PKR, (Santa
Cruz Biotechnology), and anti-mouse ISG54 (gift from G. Sen,
Cleveland, Ohio). Antibodies specific to RIG-I, MDA5, IRF-3 and
IRF-7 have been described [65]. Blots were incubated with
peroxidase-conjugated secondary antibodies (Jackson Immunor-
esearch) and visualized using ECL-Plus Immunoblotting reagents
(Amersham Biosciences).
Pharmacological inhibition of NF-kB and p38/ATF-2
To evaluate the role of NF-kB and/or p38/ATF-2 in regulating
the IFN-b gene expression in mDC, 2610
5 cells were infected with
WNV and treated with 1% DMSO (diluent control), 5 mMo r
10 mM of BAY 11-7082 (Calbiochem) a specific inhibitor of NF-
kB and/or 5 mMo r1 5mM of SB 202190 (Calbiochem), a specific
inhibitor of p38/ATF-2 for 24 h. Levels of IFN-b mRNA were
measured by qRT-PCR as described above. As a positive control,
2610
5 mDC were treated with 2 mg/ml LPS (List Biological
Laboratories) for 24 h in the absence or in the presence of BAY
11-7082 and TNF-a production was monitored by ELISA (R&D
Systems). Cytotoxicity of BAY 11-7082 and SB 202190 was
evaluated using the Celltiter-96H Aqueous One Solution Cell
proliferation Assay according to the manufacturer’s instructions
(Promega).
Statistical analysis
For in vitro experiments, an unpaired two-tailed T-test was used
to determine statistically significant differences. For viral burden
analysis, differences in log titers were analyzed by the Mann-
Whitney test. Kaplan-Meier survival curves were analyzed by the
log rank test. All data were analyzed using Prism software
(GraphPad Software).
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